(Press-News.org) Bottom Line: In patients with neuromyelitis optica spectrum disorder (NMOSD, an autoimmune inflammatory disease of the central nervous system similar to multiple sclerosis but even more debilitating), the immunosuppressant medication mycophenolate mofetil (MMF) appears to reduce the frequency of relapse, stabilize or improve disabilities and be well tolerated by patients.
Author: So-Young Huh, M.D., of the University College of Medicine, Busan, Korea, and colleagues.
Background: Disabilities from NMOSD arise due to acute attacks and just one or two attacks can lead to blindness or a walking disability. Preventing the attacks is key to preventing the resulting disabilities. Immunosuppressants such as MMF have been used as therapies to prevent relapse in patients with NMOSD. The authors sought to examine the safety and efficacy of MMF treatment.
How the Study Was Conducted: The authors conducted a three-center review that examined their experiences with 59 patients with NMOSD (24 with neuromyelitis optica and 35 with a limited form of the disease) who were treated with MMF. One of the patients discontinued use of MMF because of a rash so 58 patients were included in the drug-efficacy analysis.
Results: The median post-MMF relapse rate was lower than the pre-MMF relapse rate (0.0 vs. 1.5) and disability scores also decreased after MMF treatment (3.0 vs. 2.5). Of the patients, 35 (60 percent) were free of relapse and disability scores stabilized or improved in 53 patients (91 percent). MMF was generally well tolerated.
Discussion: "The next step will be to conduct a randomized clinical trial with long-term efficacy and safety analyses in a larger cohort that can elucidate the efficacy of MMF treatment in patients with NMOSD."
(JAMA Neurol. Published online September 8, 2014. doi:10.1001/.jamaneurol.2014.2057. Available pre-embargo to the media at http://media.jamanetwork.com.)
Editor's Note: An author made conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Editorial: Is it Time for a Randomized Trial?
In a related editorial, Bruce Cree, M.D., Ph.D, M.A.S., of the University of California, San Francisco, writes: "In this issue, Huh and colleagues report their experience treating 58 patients with NMO [neuromyelitis optica] using MMF. To my knowledge, this is the largest study of MMF treatment in patients with NMO reported thus far."
"Despite the apparent reductions in relapse rates and improvement in disability outcomes, this study has several important limitations that must be recognized before concluding that MMF is an effective treatment for NMO. Most important, there was no parallel control arm," Cree continues.
"Are we ready to conduct clinical trials with MMF or other immune suppressants in treating NMO? Given that various treatments are used empirically to treat NMO, health care professionals and patients need to know whether these empirical therapies are, in fact, effective," Cree notes.
(JAMA Neurol. Published online September 8, 2014. doi:10.1001/.jamaneurol.2014.2359. Available pre-embargo to the media at http://media.jamanetwork.com.)
Editor's Note: The author made a conflict of interest disclosure. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
INFORMATION:
Media Advisory: To contact corresponding author Ho Jin Kim, M.D., Ph.D., email hojinkim@ncc.re.kr. To contact editorial author Bruce Cree, M.D., Ph.D., call Pete Farley at 415-502-4608 or email peter.farley@ucsf.edu.
Study examines immunosuppressant effect on central nervous system disorder
2014-09-08
ELSE PRESS RELEASES FROM THIS DATE:
JAMA Internal Medicine commentary: 'Improving Prescribing for Patients Late in Life'
2014-09-08
INDIANAPOLIS -- Older adults are typically prescribed a large number of medications, often including drugs that should not be taken by individuals late in life. In a commentary published online by JAMA Internal Medicine on September 8, Regenstrief Institute investigator Greg Sachs, M.D., calls for physicians to carefully review older patients' medication lists.
According to Dr. Sachs, current prescribing guidelines fail to adequately address instances in which specific drugs are not beneficial or may even be harmful to older adults. Current guidelines also fail to identify ...
Sodium's influence on blood pressure statistically insignificant
2014-09-08
A new study published in American Journal of Hypertension finds evidence that increased Body Mass Index, age, and non-sodium dietary factors are much more closely related to increases in systolic blood pressure than sodium intake.
The study, "Relationship between nutrition and blood pressure: A cross-sectional analysis from the NutriNet-Santé study, a French web-based cohort study," measured the effects of sodium intake, Body Mass Index, physical activity, alcohol consumption, and non-sodium dietary factors on the blood pressure of 8,670 French adults and concluded ...
Agricultural revolution in Africa could increase global carbon emissions
2014-09-08
WEST LAFAYETTE, Ind. - Productivity-boosting agricultural innovations in Africa could lead to an increase in global deforestation rates and carbon emissions, a Purdue University study finds.
Historically, improvements in agricultural technology have conserved land and decreased carbon emissions at the global level: Gaining better yields in one area lessens the need to clear other areas for crops, sidestepping a land conversion process that can significantly raise the amount of carbon dioxide released into the atmosphere.
Agricultural advances in Africa, however, could ...
Watchful waiting isn't right for everyone
2014-09-08
(PHILADELPHIA) – There is an active controversy among oncologists about when to treat prostate cancer patients, with some suggesting that the word "cancer" be removed from the description of low grade disease, in order to prevent overtreatment. However a new study shows that these guidelines may not be appropriate for everyone, especially African American men.
"We know that African American men have more aggressive prostate cancer than Caucasian men," says Kosj Yamoah M.D., Ph.D., Chief Resident, Department of Radiation Oncology at Thomas Jefferson University. "Our study ...
Study traces ecological collapse over 6,000 years of Egyptian history
2014-09-08
Depictions of animals in ancient Egyptian artifacts have helped scientists assemble a detailed record of the large mammals that lived in the Nile Valley over the past 6,000 years. A new analysis of this record shows that species extinctions, probably caused by a drying climate and growing human population in the region, have made the ecosystem progressively less stable.
The study, published September 8 in Proceedings of the National Academy of Sciences (PNAS), found that local extinctions of mammal species led to a steady decline in the stability of the animal communities ...
Broken signals lead to neurodegeneration
2014-09-08
Researchers from the RIKEN Brain Science Institute in Japan, in collaboration with Juntendo University and the Japan Science and Technology Agency, have discovered that a cell receptor widely involved in intracellular calcium signaling--the IP3R receptor--can be locked into a closed state by enzyme action, and that this locking may potentially play a role in the reduction of neuron signaling seen in neurodegenerative diseases such as Huntington's and Alzheimer's disease.
In the research published today in the Proceedings of the National Academy of Sciences, the scientists ...
In directing stem cells, study shows context matters
2014-09-08
MADISON, Wis. — Figuring out how blank slate stem cells decide which kind of cell they want to be when they grow up — a muscle cell, a bone cell, a neuron — has been no small task for science.
Human pluripotent stem cells, the undifferentiated cells that have the potential to become any of the 220 types of cells in the body, are influenced in the lab dish by the cocktail of chemical factors and proteins upon which they are grown and nurtured. Depending on the combination of factors used in a culture, the cells can be coaxed to become specific types of cells.
Now, in ...
Co-flowing liquids can stabilize chaotic 'whipping' in microfluidic jets
2014-09-08
VIDEO:
This video show jets emerging from the same glass needle in chaotic whipping (left) and a steady state helical whipping. By controlling the viscosity and speed of the liquid surrounding...
Click here for more information.
Industrial wet spinning processes produce fibers from polymers and other materials by using tiny needles to eject continuous jets of liquid precursors. The electrically charged liquids ejected from the needles normally exhibit a chaotic "whipping" structure ...
Brain injuries no match for sPIF treatment
2014-09-08
New Haven, Conn. — Researchers at Yale School of Medicine and their colleagues have uncovered a new pathway to help treat perinatal brain injuries. This research could also lead to treatments for traumatic brain injuries and neurodegenerative disorders such as Alzheimer’s and Parkinson’s.
The findings are published in the Sept. 8 issue of Proceedings of the National Academy of Sciences.
The microRNA let-7 is known to cause the death of neurons in the central nervous system. The research team found that a synthetic molecule derived from the embryo called PreImplantation ...
Textbook theory behind volcanoes may be wrong
2014-09-08
In the typical textbook picture, volcanoes, such as those that are forming the Hawaiian islands, erupt when magma gushes out as narrow jets from deep inside Earth. But that picture is wrong, according to a new study from researchers at Caltech and the University of Miami in Florida.
New seismology data are now confirming that such narrow jets don't actually exist, says Don Anderson, the Eleanor and John R. McMillian Professor of Geophysics, Emeritus, at Caltech. In fact, he adds, basic physics doesn't support the presence of these jets, called mantle plumes, and the ...